Michael J Carr

9PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 25, 2023
Grade of Primary Cutaneous Leiomyosarcoma Dictates Risk for Metastatic Spread and Disease-Specific Mortality.

Michael J Carr, James Sun, William A Adams

|Aug 01, 2023
Managing valvular pathology during LVAD implantation.

Michael J Carr, Susan Ansley Smith, Mark S Slaughter

|Jul 18, 2022
Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease.

Marc D Moncrieff, Serigne N Lo, Richard A Scolyer

|Jun 08, 2021
Sentinel lymph node biopsy in melanoma: beyond histologic factors.

Michael J Carr, Federico A Monzon, Jonathan S Zager

|Dec 29, 2020
Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases.

Michael J Carr, James Sun, Jonathan B Cohen

Pageof 2